Filing Flows › Eton Pharmaceuticals (ETON) › Free cash flow
Eton Pharmaceuticals (ETON) free cash flow by quarter
Eton Pharmaceuticals' free cash flow was $35.2M in Q3 2026 (third quarter 2026), +381% from Q1 2026. Over the last 3 quarters it ranged from $7.3M (Q1 2026) to $35.2M (Q3 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $35.2M | +381% | +200% |
| Q1 2026 | $7.3M | -38% | — |
| Q3 2025 | $11.7M | — | — |
Q3 2026 at a glance
Eton Pharmaceuticals, Q3 2026: revenue $57.9M (+158% year over year), operating margin 39.7%, net earnings $35.2M, operating cash flow $35.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Eton Pharmaceuticals' free cash flow?
Eton Pharmaceuticals' free cash flow was $35.2M in Q3 2026 (third quarter 2026), +381% from Q1 2026.
How has Eton Pharmaceuticals' free cash flow changed?
Over the last 3 quarters it ranged from $7.3M (Q1 2026) to $35.2M (Q3 2026).